Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,517 | -8,546 | -6,691 | -3,123 | -9,972 |
| Depreciation Amortization | 1,516 | 1,106 | 768 | 437 | 1,685 |
| Accounts payable and accrued liabilities | 12 | 34 | 1,590 | -26 | -210 |
| Other Working Capital | 305 | 1,666 | 1,429 | 871 | 540 |
| Other Operating Activity | 4,250 | 2,374 | 438 | 590 | 5,145 |
| Operating Cash Flow | $-4,435 | $-3,367 | $-2,466 | $-1,252 | $-2,812 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 943 | 1,114 | 2,558 | 120 | 345 |
| Debt Issued | 2,123 | 300 | N/A | 1,613 | N/A |
| Common Stock Issued | 1,965 | 1,732 | 70 | N/A | 2,929 |
| Other Financing Activity | -502 | -175 | -175 | -125 | -50 |
| Financing Cash Flow | $4,529 | $2,971 | $2,453 | $1,608 | $3,224 |
| Beginning Cash Position | 494 | 494 | 494 | 474 | 82 |
| End Cash Position | 589 | 98 | 481 | 831 | 494 |
| Net Cash Flow | $95 | $-396 | $-13 | $357 | $412 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,435 | -3,367 | -2,466 | -1,252 | -2,812 |
| Free Cash Flow | -4,435 | -3,367 | -2,466 | -1,252 | -2,812 |